Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PHMMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 -2.319M
March 31, 2026 5.007M
December 31, 2025 6.738M
September 30, 2025 0.3889M
June 30, 2025 6.744M
March 31, 2025 7.370M
December 31, 2024 -8.494M
September 30, 2024 3.508M
June 30, 2024 1.282M
March 31, 2024 3.407M
December 31, 2023 6.462M
September 30, 2023 6.255M
June 30, 2023 -0.012M
March 31, 2023 8.098M
December 31, 2022 0.00
June 30, 2022 -4.259M
March 31, 2022 -2.027M
December 31, 2021 3.928M
September 30, 2021 3.820M
June 30, 2021 1.063M
March 31, 2021 -0.6817M
December 31, 2020 2.026M
September 30, 2020 26.56M
June 30, 2020 9.194M
March 31, 2020 0.7646M
Date Value
December 31, 2019 -1.112M
September 30, 2019 -0.1368M
June 30, 2019 0.5416M
March 31, 2019 -0.4973M
December 31, 2018 0.2867M
September 30, 2018 0.5117M
June 30, 2018 -0.162M
March 31, 2018 0.1168M
December 31, 2017 -1.149M
September 30, 2017 3.659M
June 30, 2017 -2.414M
March 31, 2017 0.0597M
December 31, 2016 0.1541M
September 30, 2016 -0.9152M
June 30, 2016 1.625M
March 31, 2016 0.4664M
December 31, 2015 3.153M
September 30, 2015 -10.06M
June 30, 2015 -0.521M
March 31, 2015 0.5295M
December 31, 2014 1.959M
September 30, 2014 0.2491M
June 30, 2014 0.942M
March 31, 2014 0.633M
December 31, 2013 0.7963M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Oryzon Genomics SA 0.00
Grifols SA 0.00
ACADIA Pharmaceuticals, Inc. -10.49M
Alkermes Plc 1.485B
Alnylam Pharmaceuticals, Inc. -33.56M